7AL0

Research 7AL0 on Bullrun: market cap EUR 62.81K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker7AL0
• ExchangeF
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 62.81K
• Financial periodFY2024
• RevenueSEK 57.77M
• Revenue growth-0.6%
• Net income-SEK 233.89M
• Free cash flow-SEK 212.43M

Valuation Snapshot

latest market cap is EUR 62.81K.

About 7AL0

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 3 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer;

Frequently asked questions

What is 7AL0's market cap?

7AL0's market capitalization is EUR 62.81K.

What does 7AL0 do?

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium.